免疫療法藥物市場：依治療方法、給藥途徑、適應症、通路和地區分類

Immunotherapy Drugs Market, By Therapy Type, By Route of Administration, By Indication, By Distribution Channel, By Geography

出版日期: 2026年04月01日 | 出版商:

Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，免疫療法藥物市場規模將達到2,074.5億美元，到2033年將達到4,500.7億美元。預計從2026年到2033年，該市場將以11.7%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	2074.5億美元
歷史數據時期：	2020-2024	預測期：	2026-2033
2026年至2033年預測期間的複合年成長率：	11.70%	2033年市場規模預測：	4500.7億美元

免疫療法藥物利用人體自身的免疫系統來對抗癌症和其他疾病。這些藥物透過活化現有的免疫細胞或將新的免疫細胞引入體內來刺激免疫系統。主要的免疫療法包括單株抗體、癌症疫苗、查核點抑制劑和過繼性細胞移植。由於免疫療法藥物與化療相比副作用較少，且具有長期療效，因此正逐漸成為多種癌症的標準治療方法。近年來，隨著新藥的核准及其在多種適應症中的應用日益廣泛，該市場實現了顯著成長。

市場動態

全球免疫療法市場的成長主要受癌症和其他慢性疾病在全球日益普遍的推動。新型免疫療法研發投入的增加、FDA的持續核准以及其優於其他現有治療方法的優勢，都促進了市場的發展動能。然而，這些藥物的高成本以及部分地區的報銷問題，是限制市場發展的主要因素。市場參與企業也加大對在研發線產品的投入，以拓展現有治療領域至新的適應症。

本研究的關鍵特徵

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數對全球免疫療法藥物市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球免疫療法藥物市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等行業相關人員相關者。
相關人員可以透過分析全球免疫療法藥物市場中使用的各種策略矩陣輕鬆做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第9章競爭情勢

公司簡介
- Bristol-Myers Squibb Company
- Pfizer Inc
- Novartis AG
- Merck & Co., Inc.
- AstraZeneca
- Amgen Inc.
- GSK plc.
- Gilead Sciences, Inc.
- Johnson & Johnson
- Actym Therapeutics, Inc.
- Fate Therapeutics
- Gritstone bio
- Incyte
- Acumen Pharmaceuticals, Inc
- Arcus Biosciences, Inc.
- immunitybio inc
- Autolus Therapeutics
- ADC Therapeutics SA.
- BioNTech SE
- Cellectis

第10章分析師建議

機會分析
一致的機會地圖

第11章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI525

Immunotherapy Drugs Market is estimated to be valued at USD 207.45 Bn in 2026 and is expected to reach USD 450.07 Bn by 2033, growing at a compound annual growth rate (CAGR) of 11.7% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 207.45 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	11.70%	2033 Value Projection:	USD 450.07 Bn

Immunotherapy drugs utilize the body's immune system to fight cancer and other diseases. These drugs stimulate the immune system by either boosting existing immune cells or introducing new immune cells into the body. The major types of immunotherapies include monoclonal antibodies, cancer vaccines, checkpoint inhibitors, and adoptive cell transfer therapies. Immunotherapy drugs are increasingly becoming the standard of care for various cancer types as these have been shown to provide long-lasting response rates with milder side effects compared to chemotherapy. The market has witnessed significant growth over the past few years driven by new drug approvals and increasing adoption across different disease indications.

Market Dynamics

Global immunotherapy drugs market growth is driven by rising prevalence of cancer and other chronic diseases worldwide. The market has gained momentum due to factors such as an increase in R&D funding for developing novel immunotherapies, consistent FDA approvals of immunotherapies, and superiority over other available treatment options. However, high costs associated with these drugs along with reimbursement issues in some regions act as key restraints for this market. The market players are also investing in pipeline products for expanding the current treatment landscape to new indications.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global immunotherapy drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study includes Bristol-Myers Squibb Company, Pfizer Inc, Novartis AG, Merck & Co., Inc., AstraZeneca, Amgen Inc., GSK plc., Gilead Sciences, Inc., Johnson & Johnson, Actym Therapeutics, Inc., Fate Therapeutics., Gritstone bio, Incyte, Acumen Pharmaceuticals, Inc, Arcus Biosciences, Inc., immunitybio inc, Autolus Therapeutics, ADC Therapeutics SA., BioNTech SE, and Cellectis.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global immunotherapy drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global immunotherapy drugs market.

Market Segmentation

Therapy Type (Revenue, USD Bn, 2021 - 2033)
Immune checkpoint inhibitors
Monoclonal antibodies
- Naked monoclonal antibodies
- Conjugated monoclonal antibodies
- Bispecific monoclonal antibodies
Vaccines
- Preventive Vaccines
- Therapeutic Vaccines
Adoptive Cell Therapies
- Tumor-infiltrating lymphocyte (TIL) therapy
- CAR T-cell therapy
- Engineered T-cell receptor (TCR) therapy
- Natural killer (NK) cell therapy
Immune System Modulators
- Interferons
- Immunomodulators (IMiDs)
- Interleukins
Oncolytic Virus Therapy
Route of Administration
Intravenous (IV)
Oral
Intramuscular
Subcutaneous
Others
Indication
Cancer
- Lung Cancer
- Lymphoma
- Breast Cancer
- Skin Cancer
- Bladder Cancer
- Colorectal Cancer
- Kidney Cancer
- Others
Autoimmune Diseases
Others
Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Region
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Company Profiles
Bristol-Myers Squibb Company
Pfizer Inc.
Novartis AG
Merck & Co., Inc.
AstraZeneca
Amgen Inc.
GSK plc.
Gilead Sciences, Inc.
Johnson & Johnson
Actym Therapeutics, Inc.
Fate Therapeutics.
Gritstone bio
Incyte
Acumen Pharmaceuticals, Inc.
Arcus Biosciences, Inc.
immunitybio inc
Autolus Therapeutics
ADC Therapeutics SA.
BioNTech SE
Cellectis

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Therapy Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Indication
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Technology Overview
Regulatory Scenario
Pricing Analysis
PEST Analysis

4. Global Immunotherapy Drugs Market, By Therapy Type, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Immune checkpoint inhibitors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Monoclonal antibodies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  - Naked monoclonal antibodies
  - Conjugated monoclonal antibodies
  - Bispecific monoclonal antibodies
Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  - Preventive Vaccines
  - Therapeutic Vaccines
Adoptive Cell Therapies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  - Tumor-infiltrating lymphocyte (TIL) therapy
  - CAR T-cell therapy
  - Engineered T-cell receptor (TCR) therapy
  - Natural killer (NK) cell therapy
Immune System Modulators
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  - Interferons
  - Immunomodulators (IMiDs)
  - Interleukins
Oncolytic Virus Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Immunotherapy Drugs Market, By Route of Administration, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Intravenous (IV)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Intramuscular
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Subcutaneous
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Immunotherapy Drugs Market, By Indication, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  - Lung Cancer
  - Lymphoma
  - Breast Cancer
  - Skin Cancer
  - Bladder Cancer
  - Colorectal Cancer
  - Kidney Cancer
  - Others
Autoimmune Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Immunotherapy Drugs Market, By Distribution Channel, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

8. Global Immunotherapy Drugs Market, By Region, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Bristol-Myers Squibb Company
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pfizer Inc
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Novartis AG
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Merck & Co., Inc.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- AstraZeneca
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Amgen Inc.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- GSK plc.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Gilead Sciences, Inc.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Johnson & Johnson
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Actym Therapeutics, Inc.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Fate Therapeutics
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Gritstone bio
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Incyte
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Acumen Pharmaceuticals, Inc
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Arcus Biosciences, Inc.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- immunitybio inc
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Autolus Therapeutics
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- ADC Therapeutics SA.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- BioNTech SE
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Cellectis
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies